Insider Transactions in Q2 2022 at Compass Therapeutics, Inc. (CMPX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.37%
|
$40,000
$2.8 P/Share
|
|
Jun 16
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.38%
|
$40,000
$2.34 P/Share
|
|
Jun 13
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
30,000
+0.56%
|
$60,000
$2.29 P/Share
|
|
Jun 06
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
30,000
+0.57%
|
$60,000
$2.83 P/Share
|
|
Jun 01
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.38%
|
$60,000
$3.03 P/Share
|
|
May 26
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,000
+0.38%
|
$60,000
$3.04 P/Share
|
|
May 23
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
18,355
+0.35%
|
$36,710
$2.72 P/Share
|
|
May 17
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
20,215
+0.39%
|
$40,430
$2.47 P/Share
|
|
May 13
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
30,722
+0.21%
|
$61,444
$2.49 P/Share
|
|
May 13
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
30,722
+0.21%
|
$61,444
$2.49 P/Share
|
|
May 12
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
97,094
+0.65%
|
$194,188
$2.35 P/Share
|
|
May 12
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
97,094
+0.65%
|
$194,188
$2.35 P/Share
|
|
May 11
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
64,700
+0.44%
|
$64,700
$1.79 P/Share
|
|
May 11
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
64,700
+0.44%
|
$64,700
$1.79 P/Share
|
|
May 10
2022
|
Thomas J. Schuetz PRESIDENT |
BUY
Open market or private purchase
|
Direct |
27,836
+0.54%
|
$27,836
$1.8 P/Share
|
|
May 10
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
24,447
+0.17%
|
$24,447
$1.6 P/Share
|
|
May 10
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
24,447
+0.17%
|
$24,447
$1.6 P/Share
|
|
May 09
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
90,712
+0.62%
|
$90,712
$1.56 P/Share
|
|
May 09
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
90,712
+0.62%
|
$90,712
$1.56 P/Share
|
|
May 06
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
10,200
+0.07%
|
$10,200
$1.63 P/Share
|
|
May 06
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
10,200
+0.07%
|
$10,200
$1.63 P/Share
|